This is a news list that clearly organizes the latest news, research trends, legal regulations, and industry trends related to cannabis, cannabinoids, and psychedelics.
We've organized the cannabis industry category updates chronologically, and made it possible to see links to relevant guides on the same screen as needed.
October 11, 2026: The report covered a range of topics including European payment regulatory issues, the bankruptcy of a Dutch medical cannabis company, a $10 million settlement in a US ownership dispute in Missouri, and 10 years of hospitalization data from Victoria, Australia. We'll explore these situations involving significant financial and large-scale events in a relatable way. Overview…
AI is transforming the investment landscape, and the choice of extraction technology is now crucial to profitability. This update, directly impacting both finance (fundraising and asset management) and manufacturing (extraction costs), will be organized with quantitative data and relatable examples. Overview: On the investment side, AI is deeply involved in the actions of major US asset management companies. Vanguard's...
US sales are showing a slight increase, indicating robust current demand, while the bankruptcy of a long-established healthcare company is sending ripples through Europe. Capital markets remain focused on assessing the "quality of debt" and "regulatory changes," and corporate investments in equipment and quality are becoming increasingly pragmatic. Overview: US sales across 16 markets for the past 12 months totaled $246 billion (compared to the same period last year)...
Regulatory compliance efforts are underway in Washington state, and Europe has emerged as a new growth axis for North American investors. While industrial hemp production is surging in the US, value-related challenges are becoming clearer. In the medical field, new insights have emerged regarding pain relief for endometriosis, a contributing factor to dysmenorrhea, and in business and operational areas, investment in human resources and AI utilization are gaining traction...
To help you supplement your understanding of the news as you read, we've compiled a summary of the systems, terminology, and introductory points here.
This is an entry point to a guide that organizes information on system changes and how to interpret government announcements.
This can be used as a place to refer to ingredient names or technical terms when they come up.
This is an entry point for those who want to transition directly from the news list into the learning process.
Changes in medical marijuana sales models, regulations, and distribution channels are underway in various locations. This report summarizes the developments, from corporate actions to policies, that will directly impact future revenue structures and cost structures. Overview: The "pharmacy-style" medical marijuana sales model being promoted in Utah, USA, is a potential model for the entire nation, with stricter clinical advisory systems and inventory management...
From stricter and more relaxed regulations, shifts in distribution tracking, changes in consumer behavior, to basic research—today, we'll grasp the big picture through "quantities." Overview: In the US, a concentration of arrests and a stagnation in retail licensing are occurring simultaneously, along with lawsuits over the transparency of supply chains. The EU has clarified its THC regulations for hemp tea starting in 2027 using numerical data. ...
The Netherlands faces simultaneous challenges in the supply chain of medical cannabis, quality standards gaps in the US market, and uncertainties in legal and payment infrastructure. This analysis will examine these issues from regulatory, corporate, market, and research perspectives, focusing on quantitative data. Overview: In the Netherlands, a major supplier of medical cannabis is facing a financial crisis, potentially lasting up to 10 months…
Overview Today, we will organize information based on quantitative data, focusing on four pillars: "Regulatory and policy restructuring," "Corporate acquisitions and financing trends," "Governance and law enforcement," and "Product differentiation (terpenes)." By paying attention to the "increases and decreases" and "ratios" of these numbers, we can see the current state of the industry. For example, in the United States, while the system is progressing due to a review of federal classifications, market renewal is occurring at the state level...
The news was filled with topics directly related to funding and supply chains, including regulatory uncertainty, equipment trading trends, expanding access to healthcare, and the positioning of hemp building materials. This report provides an overview from the perspectives of companies, markets, research, and regulations, focusing primarily on quantitative information. Overview: The hemp industry is positioned as an estimated $380 billion sector...
Overview | This section summarizes the latest topics in regulations, corporate trends, markets, and research, focusing on quantitative information. Relatable analogies are included to help readers grasp the monetary value and scale. Overview: In Europe, regulatory and enforcement trends in the Netherlands dominated the news, with the worsening financial situation (payment deferrals) of major medical cannabis companies highlighting industry risks...
According to the US specialist media outlet MJBizDaily, cannabis sales in New York State are on track to reach record highs, but recently there have been signs of a slowdown, and the outlook is not expected to reach the previously bullish forecasts. While quantitative details (sales figures, growth rate, number of stores, tax revenue, etc.) are not explicitly stated in the article, there appears to be a change in the market's "speed"...
Today saw significant developments in three areas: regulation, healthcare, and the market, including an increase in health reports following a vape product recall in Colorado, USA; the emergence of a new plant-derived dronabinol (THC) spray in the UK; a six-month closure of coffee shops in the Netherlands; and continued legal ambiguity in Spain. In addition, 1.1 million people in the US...
Regulatory uncertainty in the US remains strong, putting a brake on supply chains and investment sentiment, while in the UK, pharmaceutical-grade supply chain coordination has advanced. In Japan, pet CBD products have received "resource-driven" updates, with strengthened formulations and increased volume while maintaining prices. On the research front, quantitative data on CBD analysis, formulation, and clinical trials is accumulating...
Overview: Today saw several developments directly impacting funding and supply, affecting both regulation and corporate finance. These included the temporary suspension of the US federal cannabis rescheduling hearing, worsening financial conditions for established European medical cannabis companies, a market reform proposal from the city of Los Angeles, and the publication of a blueprint for global regulatory harmonization. Glossary: "Rescheduling" refers to...
Regulations and corporate actions intersected across the Americas, Europe, and Asia. This overview focuses on quantitative information, including the "$2 billion" size of the Florida medical cannabis market, a $29,000 bribery case in New Jersey, and a payment moratorium for a major Dutch medical cannabis company. Overview: The medical cannabis market in Florida is approximately $2 billion...
The economy surrounding cannabinoids/cannabis is caught in a three-way struggle between "oversupply," "regulation," and "the quality of demand." Today, we'll examine the feed market, which is attracting attention as a potential outlet for the US hemp surplus; the cross-border risks indicated by severe penalties in Southeast Asia; and the redefinition of demand suggested by research (including "extra-component effects" such as stress reduction and the actual usage patterns of the elderly), using quantitative data...
European THC-A logistics routes face the risk of contraction due to regulatory changes, and the outcome of rescheduling in the US is determining the future of hemp beverages. Simultaneously, US cannabis tax revenue reached $158 billion in five years, and new insights have been gained into the neuroprotective mechanisms of CBD/CBG in research. Overview: THC-A for Europe...
Stricter regulations in North America, the adoption of AI and access to finance, advanced research, and consumer price consciousness are all simultaneously driving the market. In particular, the reliability of testing, funding and credit, and safety policies are crucial themes that will influence future profitability and brand value. Overview: Maryland is implementing multi-testing measures to ensure the accuracy of THC labeling...
Today, we'll take a comprehensive overview, focusing on quantitative data directly impacting funding, taxes, and demand, covering everything from North American regulations and market trends to European pilot programs, Asian institutional design, and labor, veterinary, and public health aspects. We've included familiar conversions to make the figures easy to understand, even for middle school students. Overview: Regulatory Aspects: The adult market in Virginia is projected to be "billion dollar"...
Regulatory instability and market maturation are occurring simultaneously in Europe, the US, Mexico, and the Netherlands. While index inclusion broadens the reach of institutional funding, increased investigations and law enforcement by state judicial authorities are driving up compliance costs. On the policy front, the US Insurance Access Act, the Dutch pilot project, and the Mexican Supreme Court's actions are impacting supply chains and product categories…
